연구동향 분석

Prevention and Management of Cerebral Small Vessel Disease

Vincent Mok Jong S. Kim 2015년

논문상세정보
인용/피인용
' Prevention and Management of Cerebral Small Vessel Disease' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • prevention
  • small vessel disease
  • treatment
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,773 1

0.0%

' Prevention and Management of Cerebral Small Vessel Disease' 의 참고문헌

  • “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia
    Bousser MG Stroke 14 : 5 ~ 14 [1983]
  • White matter lucencies on computed tomography, subacute arteriosclerotic encephalopathy (binswanger’s disease), and blood pressure
    McQuinn BA Stroke 18 : 900 ~ 905 [1987]
  • White matter hyperintensities on mri in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home
    Ylikoski A Stroke 26 : 1171 ~ 1177 [1995]
  • Vascular dementia due to cardiac arrhythmias and systemic hypotension
    Sulkava R Acta Neurologica Scandinavica 76 : 123 ~ 128 [1987]
  • Two clinically distinct lacunar infarct entities? A hypothesis
    Boiten J Stroke 24 : 652 ~ 656 [1993]
  • Triflusal vs aspirin for prevention of cerebral infarction : a randomized stroke study
    Culebras A Neurology 62 : 1073 ~ 1080 [2004]
  • Tpa treatment for acute ischaemic stroke in patients with leukoaraiosis
    Aries MJ Eur J Neurol 17 : 866 ~ 870 [2010]
  • Thrombolysis in acute stroke patients with cerebral small vessel disease
    Pantoni L Cerebrovasc Dis 37 : 5 ~ 13 [2014]
  • The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC study
    Liao D Neuroepidemiology 16 : 149 ~ 162 [1997]
  • The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: Systematic review and meta-analysis
    Debette S BMJ 341 : c3666 ~ [2010]
  • The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study
    van Dijk EJ Hypertension 44 : 625 ~ 630 [2004]
  • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study group. Tissue plasminogen activator for acute ischemic stroke
    N Engl J Med 333 : 1581 ~ 1587 [1995]
  • The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke
    Gent M Lancet 1 : 1215 ~ 1220 [1989]
  • Strong independent correlation of proteinuria with cerebral microbleeds in patients with stroke and transient ischemic attack
    Ovbiagele B Arch Neurol 67 : 45 ~ 50 [2010]
  • Stroke risk profile predicts white matter hyperintensity volume : the Framingham Study
    Jeerakathil T Stroke 35 : 1857 ~ 1861 [2004]
  • Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage
    Haussen DC Stroke 43 : 2677 ~ 2681 [2012]
  • Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting
    Cordonnier C Brain 130 : 1988 ~ 2003 [2007]
  • Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam study
    Wieberdink RG Arterioscler Thromb Vasc Biology 31 : 2982 ~ 2989 [2011]
  • Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study
    Bezerra DC Neurology 78 : 102 ~ 108 [2012]
  • Risk factor profile of cerebral small vessel disease and its subtypes
    Khan U J Neurol Neurosurg Psychiatry 78 : 702 ~ 706 [2007]
  • Results of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial by stroke subtypes
    Amarenco P Stroke 40 : 1405 ~ 1409 [2009]
  • Relationship between blood pressure and subcortical lesions in healthy elderly people
    Goldstein IB Stroke 29 : 765 ~ 772 [1998]
  • Prospective study of single and multiple lacunar infarcts using magnetic resonance imaging: risk factors, recurrence, and outcome in 175 consecutive cases
    Arauz A Stroke 34 : 2453 ~ 2458 [2003]
  • Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study
    Gouw AA Stroke 39 : 1414 ~ 1420 [2008]
  • Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study
    Schmidt R Lancet 361 : 2046 ~ 2048 [2003]
  • Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study
    van Dijk EJ, Prins Stroke 39 : 2712 ~ 2719 [2008]
  • Previous statin use is not associated with an increased prevalence or degree of gradient-echo lesions in patients with acute ischemic stroke or transient ischemic attack
    Day JS Stroke 42 : 354 ~ 358 [2011]
  • Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam Scan study
    Poels MM Stroke 41 : S103 ~ 106 [2010]
  • Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities
    Xiong Y Neurotherapeutics 11 : 606 ~ 611 [2014]
  • Predictors for cognitive decline in patients with confluent white matter hyperintensities
    Mok V Alzheimers Dement 8 (Suppl) : S96 ~ S103 [2012]
  • Plasma vitamin B12 status and cerebral white-matter lesions
    de Lau LM J Neurol Neurosurg Psychiatry 80 : 149 ~ 157 [2009]
  • Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons: the cardiovascular health study
    Longstreth WT Jr Arch Neurol 61 : 67 ~ 72 [2004]
  • Plasma folate concentration and cognitive performance : Rotterdam Scan Study
    de Lau LM Am J Clin Nutrition 86 : 728 ~ 734 [2007]
  • Periventricular venous collagenosis: association with leukoaraiosis
    Moody DM Radiology 194 : 469 ~ 476 [1995]
  • PROGRESS-Perindopril protection Against Recurrent Stroke Study: characteristics of the study population at baseline
    Progress Management Committee J Hypertens 17 : 1647 ~ 1655 [1999]
  • Outcome by stroke etiology in patients receiving thrombolytic treatment: Descriptive subtype analysis
    Mustanoja S Stroke 42 : 102 ~ 106 [2011]
  • Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis
    Dannenberg S Stroke 45 : 2900 ~ 2905 [2014]
  • Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
    Wardlaw JM Lancet Neurol 12 : 822 ~ 838 [2013]
  • Multiple cerebral microbleeds: mri marker of a diffuse hemorrhage-prone state
    Chalela JA J Neuroimaging 14 : 54 ~ 57 [2004]
  • Midlife cardiovascular risk factors and brain morphology in identical older male twins
    Carmelli D Neurology 52 : 1119 ~ 1124 [1999]
  • Microarray rna expression analysis of cerebral white matter lesions reveals changes in multiple functional pathways
    Simpson JE Stroke 40 : 369 ~ 375 [2009]
  • Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: Longitudinal results of the Austrian Stroke Prevention Study
    Markus HS Stroke 36 : 1410 ~ 1414 [2005]
  • Managing pad with multiple platelet inhibitors: the effect of combination therapy on bleeding time
    Wilhite DB J Vasc Surg 38 : 710 ~ 713 [2003]
  • Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants
    Schmidt R Stroke 27 : 2043 ~ 2047 [1996]
  • MRI detection of new microbleeds in patients with ischemic stroke: five-year cohort follow-up study
    Gregoire SM Stroke 41 : 184 ~ 186 [2010]
  • Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions
    Lee SH Stroke 33 : 2845 ~ 2849 [2002]
  • Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI cohort
    Dufouil C Neurology 56 : 921 ~ 926 [2001]
  • Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort
    Brickman AM Arch Neurol 67 : 564 ~ 569 [2010]
  • Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke
    Neumann-Haefelin T Stroke 37 : 2463 ~ 2466 [2006]
  • Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke
    Palumbo V Neurology 68 : 1020 ~ 1024 [2007]
  • Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the cardiovascular health study
    Longstreth WT Jr Arch Neurol 55 : 1217 ~ 1225 [1998]
  • Joint effect of mid- and late-life blood pressure on the brain: the Ages-Reykjavik study
    Muller M Neurology 82 : 2187 ~ 2195 [2014]
  • Intravenous thrombolysis in patients with stroke attributable to small artery occlusion
    Fluri F Eur J Neurol 17 : 1054 ~ 1060 [2010]
  • Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: The Cardiovascular Health Study
    Longstreth WT Jr Stroke 36 : 56 ~ 61 [2005]
  • Incidence of cerebral microbleeds in the general population: the Rotterdam Scan study
    Poels MM Stroke 42 : 656 ~ 661 [2011]
  • Incidence of cerebral microbleeds : a longitudinal study in a memory clinic population
    Goos JD Neurology 74 : 1954 ~ 1960 [2010]
  • Importance of leukoaraiosis on ct for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study
    Demchuk AM Cerebrovasc Dis 26 : 120 ~ 125 [2008]
  • Hypertension and cerebral white matter lesions in a prospective cohort study
    de Leeuw FE Brain 125 : 765 ~ 772 [2002]
  • Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke
    Jimenez-Conde J Stroke 41 : 437 ~ 442 [2010]
  • Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan study
    Vermeer SE Ann Neurol 51 : 285 ~ 289 [2002]
  • Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction
    Hassan A Brain 127 : 212 ~ 219 [2004]
  • Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study
    Goldstein LB Neurology 70 : 2364 ~ 2370 [2008]
  • Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association
    Furie KL Stroke 42 : 227 ~ 276 [2011]
  • Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association
    Jauch EC Stroke 44 : 870 ~ 947 [2013]
  • Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium
    Fornage M Ann Neurology 69 : 928 ~ 939 [2011]
  • Genetic associations with brain microbleeds: systematic review and meta-analyses
    Maxwell SS Neurology 77 : 158 ~ 167 [2011]
  • Efficacy of intravenous thrombolysis according to stroke subtypes: the Madrid Stroke Network Data
    Fuentes B Eur J Neurol 19 : 1568 ~ 1574 [2012]
  • Efficacy of IV tissue plasminogen activator in acute stroke: does stroke subtype really matter?
    Hsia AW Neurology 61 : 71 ~ 75 [2003]
  • Effects of statins on the progression of cerebral white matter lesion: post hoc analysis of the ROCAS (Regression Of Cerebral Artery Stenosis) study
    Mok VC J Neurol 256 : 750 ~ 757 [2009]
  • Effects of statins on progression of subclinical brain infarct
    Fu JH Cerebrovasc Dis 30 : 51 ~ 56 [2010]
  • Effects of clopidogrel added to aspirin in patients with recent lacunar stroke
    Benavente OR N Engl J Med 367 : 817 ~ 825 [2012]
  • Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke : the PROGRESS(Perindopril pROtection aGainst REcurrent Stroke Study)magnetic resonance imaging substudy
    Dufouil C Circulation 112 : 1644 ~ 1650 [2005]
  • Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual dData ANalysis of Antihypertensive intervention trials) project collaborators
    Gueyffier F Stroke 28 : 2557 ~ 2562 [1997]
  • Do lacunar strokes benefit from thrombolysis? Evidence from the registry of the Canadian Stroke Network
    Shobha N Int J Stroke 8 (Suppl) : 45 ~ 49 [2013]
  • Diversity of single small subcortical infarctions according to infarct location and parent artery disease:analysis of indicators for small vessel disease and atherosclerosis
    Nah HW Stroke 41 : 2822 ~ 2827 [2010]
  • Distinctive RNA expression profiles in blood associated with white matter hyperintensities in brain
    Xu H Stroke 41 : 2744 ~ 2749 [2010]
  • Differential risk factors for lacunar stroke depending on the mri (white and red) subtypes of microangiopathy
    Park JH PLoS One 7 : e44865 ~ [2012]
  • Clinical investigation of the protective effects of palm vitamin E tocotrienols on brain white matter
    Gopalan Y Stroke 45 : 1422 ~ 1428 [2014]
  • Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study
    Longstreth WT Jr Stroke 27 : 1274 ~ 1282 [1996]
  • Cilostazol reduces the risk of hemorrhagic infarction after administration of tissue-type plasminogen activator in a murine stroke model
    Kasahara Y Stroke 43 : 499 ~ 506 [2012]
  • Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damage
    Nonaka Y Neurosci Lett 452 : 156 ~ 161 [2009]
  • Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats
    Lee JH J Pharmacol Exp Ther 308 : 896 ~ 903 [2004]
  • Cilostazol for Prevention of Secondary Stroke (CSPS2): an aspirin-controlled, double-blind, randomised non-inferiority trial
    Shinohara Y Lancet Neurol 9 : 959 ~ 968 [2010]
  • Cilostazol decreases cerebral arterial pulsatility in patients with mild white matter hyperintensities: subgroup analysis from the effect of cilostazol in acute lacunar infarction based on pulsatility index of transcranial doppler (ECLIPse) study
    Han SW Cerebrovasc Dis 38 : 197 ~ 203 [2014]
  • Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study
    Huang Y Lancet Neurol 7 : 494 ~ 499 [2008]
  • Changes in vascular risk factors from midlife to late life and white matter lesions: a 20-year follow-up study
    Vuorinen M Dementia Geriatr Cog Disorders 31 : 119 ~ 125 [2011]
  • Cerebrospinal fluid proteins in patients with leucoaraiosis: possible abnormalities in blood-brain barrier function
    Pantoni L J Neurol Sci 115 : 125 ~ 131 [1993]
  • Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly
    Bakker SL Neurology 52 : 578 ~ 583 [1999]
  • Cerebral microbleeds: is antithrombotic therapy safe to administer?
    Wang Z Stroke 45 : 2811 ~ 2817 [2014]
  • Cerebral microbleeds are predictive of mortality in the elderly
    Altmann-Schneider I Stroke 42 : 638 ~ 644 [2011]
  • Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis
    Charidimou A J Neurol Neurosurg Psychiatry 84 : 277 ~ 280 [2013]
  • C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study
    Schmidt R Stroke 37 : 2910 ~ 2916 [2006]
  • C-reactive protein and cerebral small-vessel disease : the Rotterdam Scan study
    van Dijk EJ Circulation 112 : 900 ~ 905 [2005]
  • Brain microbleeds relate to higher ambulatory blood pressure levels in first-ever lacunar stroke patients
    Staals J Stroke 40 : 3264 ~ 3268 [2009]
  • Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial
    Benavente OR Lancet 382 : 507 ~ 515 [2013]
  • Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review
    Rashid P Stroke 34 : 2741 ~ 2748 [2003]
  • Blood pressure and white-matter disease progression in a biethnic cohort: atherosclerosis Risk In Communities (ARIC) study
    Gottesman RF Stroke 41 : 3 ~ 8 [2010]
  • Bleeding Risk Analysis in Stroke Imaging Before ThromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients
    Fiehler J Stroke 38 : 2738 ~ 2744 [2007]
  • Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2
    Uchiyama S Cerebrovasc Dis 37 : 296 ~ 303 [2014]
  • B vitamins and magnetic resonance imaging-detected ischemic brain lesions in patients with recent transient ischemic attack or stroke: the VITAmins TO Prevent Stroke (VITATOPS) MRI-substudy
    Cavalieri M Stroke 43 : 3266 ~ 3270 [2012]
  • Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial
    Halkes PH Lancet 367 : 1665 ~ 1673 [2006]
  • Aspirin and ticlopidine for prevention of recurrent stroke in black patients : A randomized trial
    Gorelick PB JAMA 289 : 2947 ~ 2957 [2003]
  • Are acute infarcts the cause of leukoaraiosis? Brain mapping for 16 consecutive weeks
    Conklin J Ann Neurol 76 : 899 ~ 904 [2014]
  • Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: The three-city (3c)-dijon magnetic resonance imaging study
    Godin O Circulation 123 : 266 ~ 273 [2011]